In Westlaw Today, Attorneys Discuss FDA Guidance on Communication of Scientific Information on Unapproved Uses of Medical Products

In The News
November 8, 2023

In Westlaw Today, life sciences regulatory & compliance partners Kellie Combs, Greg Levine and Joshua Oyster and counsel Sarah Blankstein discussed the

The authors explain that it remains to be seen whether the changes FDA proposes in the draft guidance will in practice provide meaningful flexibility or lead to additional scrutiny over manufacturer communications regarding truthful, non-misleading information about unapproved uses for approved or cleared products.